File(s) under permanent embargo
Loss of mitochondrial fatty acid β-oxidation protein short-chain Enoyl-CoA hydratase disrupts oxidative phosphorylation protein complex stability and function
journal contributionposted on 2022-11-17, 05:34 authored by Harrison BurginHarrison Burgin, AJ Sharpe, S Nie, Mark ZiemannMark Ziemann, JJ Crameri, D Stojanovski, J Pitt, A Ohtake, K Murayama, Matthew McKenzieMatthew McKenzie
Short-chain enoyl-CoA hydratase 1 (ECHS1) is involved in the second step of mitochondrial fatty acid β-oxidation (FAO), catalysing the hydration of short-chain enoyl-CoA esters to short-chain 3-hyroxyl-CoA esters. Genetic deficiency in ECHS1 (ECHS1D) is associated with a specific subset of Leigh Syndrome, a disease typically caused by defects in oxidative phosphorylation (OXPHOS). Here, we examined the molecular pathogenesis of ECHS1D using a CRISPR/Cas9 edited human cell ‘knockout’ model and fibroblasts from ECHS1D patients. Transcriptome analysis of ECHS1 ‘knockout’ cells showed reductions in key mitochondrial pathways, including the tricarboxylic acid cycle, receptor-mediated mitophagy and nucleotide biosynthesis. Subsequent proteomic analyses confirmed these reductions and revealed additional defects in mitochondrial oxidoreductase activity and fatty acid β-oxidation. Functional analysis of ECHS1 ‘knockout’ cells showed reduced mitochondrial oxygen consumption rates when metabolising glucose or OXPHOS complex I-linked substrates, as well as decreased complex I and complex IV enzyme activities. ECHS1 ‘knockout’ cells also exhibited decreased OXPHOS protein complex steady-state levels (complex I, complex III2, complex IV, complex V and supercomplexes CIII2/CIV and CI/CIII2/CIV), which were associated with a defect in complex I assembly. Patient fibroblasts exhibit varied reduction of mature OXPHOS complex steady-state levels, with defects detected in CIII2, CIV, CV and the CI/CIII2/CIV supercomplex. Overall, these findings highlight the contribution of defective OXPHOS function, in particular complex I deficiency, to the molecular pathogenesis of ECHS1D.
Publication classificationC1 Refereed article in a scholarly journal
Read the peer-reviewed publication
ASSEMBLY FACTORBiochemistry & Molecular BiologyCELL-PROLIFERATIONDISEASEECHS1 deficiencyECHS1 DEFICIENCYENCEPHALOPATHYEXPRESSIONfatty acid oxidationHEPATOCELLULAR-CARCINOMALEIGH-SYNDROMELife Sciences & Biomedicinemitochondriamitochondrial diseaseMUTATIONSOXPHOSPHENOTYPIC SPECTRUMScience & Technologyshort-chain enoyl-CoA hydratase2.1 Biological and endogenous factorsSchool of Life and Environmental SciencesFaculty of Science Engineering and Built Environment